Evidence map›Paper›PMID 27637337›Full record

ArticleProstaglandins, leukotrienes, and essential fatty acids2016

Smoking and red blood cell phospholipid membrane fatty acids.

H J Murff, H A Tindle, M J Shrubsole, Q Cai, W Smalley, G L Milne, L L Swift, R M Ness, W Zheng

Abstract read
In one paragraph

Article in Prostaglandins, leukotrienes, and essential fatty acids, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

H J MurffDivision of General Medicine and Public Health, Vanderbilt University Medicine Center, Nashville, TN, United States; GRECC, Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN, United States; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, United States. Electronic address: harvey.j.murff@vanderbilt.edu.
H A TindleDivision of General Medicine and Public Health, Vanderbilt University Medicine Center, Nashville, TN, United States; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, United States.
M J ShrubsoleGRECC, Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN, United States; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, United States; Division of Epidemiology, Vanderbilt University Medical Center, United States.
Q CaiVanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, United States; Division of Epidemiology, Vanderbilt University Medical Center, United States.
W SmalleyDivision of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Center, United States; Department of Health Policy, Vanderbilt University Medical Center, United States.
G L MilneDivision of Clinical Pharmacology, Vanderbilt University Medical Center, United States.
L L SwiftDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, United States.
R M NessDivision of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Center, United States.
W ZhengGRECC, Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN, United States; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, United States; Division of Epidemiology, Vanderbilt University Medical Center, United States.

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
Understanding and Controlling p120 Dysfunction in CRCP50CA095103 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COFFEY, ROBERT J. · 2002 to 2017
$33.6M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
Tumor Markers and Recurrent Adenomas: A Follow-up StudyR01CA097386 · NCI · VANDERBILT UNIVERSITY · PI ZHENG, WEI · 2002 to 2006
$3.6M
PCSK9, Lipoprotein receptors, and AtherosclerosisR01HL106845 · NHLBI · VANDERBILT UNIVERSITY · PI FAZIO, SERGIO · 2011 to 2014
$2.0M
Fatty acid desaturase activity, fish oil and colorectal cancer chemopreventionR01CA160938 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MURFF, HARVEY J. · 2011 to 2014
$1.3M
Long-Chain Fatty Acids, Oxidative Stress and Colorectal Neoplasm RiskR01CA143288 · NCI · VANDERBILT UNIVERSITY · PI MURFF, HARVEY J. · 2010 to 2013
$1.0M
NCI NIH HHS P30 CA068485NCI NIH HHS P50 CA095103NCI NIH HHS R01 CA097386NCI NIH HHS R01 CA143288NCI NIH HHS R01 CA160938NHLBI NIH HHS R01 HL106845NIDDK NIH HHS P30 DK020593
6 · The paper itself

Abstract

Smoking is associated with lower n-3 long chain polyunsaturated fatty acids (LCPUFA) concentrations; however, limited studies have accounted for dietary PUFA intake or whether tobacco dose or smoking duration influences this association. We measured red blood cell phospholipid (RBC) membrane concentrations of fatty acids in 126 current smokers, 311 former smokers, and 461 never smokers using gas liquid chromatography and tandem mass spectrometry. Smokers had lower RBC membrane percentages of total n-3 LCPUFAs compared to former smokers or never smokers (median percent: 5.46, [interquartile range (IQR) 4.52, 6.28] versus 6.39; [IQR: 5.18, 7.85] versus 6.59; [IQR 5.34, 8.01]) (p<0.001) and this association remained after adjusting for dietary PUFA intake. Duration of smoking and cigarettes per day were not associated with RBC membrane n-3 LCPUFA differences. Smoking is associated with lower n-3 LCPUFA RBC membrane percentages and this association was not influenced by diet or smoking dose or duration.

Indexed as

AdultAgedErythrocyte MembraneErythrocytesFatty AcidsFatty Acids, Omega-3FemaleGas Chromatography-Mass SpectrometryHumansMaleMiddle AgedPhospholipidsSmokingFatty AcidsFatty Acids, Omega-3PhospholipidsFatty acid, unsaturatedOxidative stressTobacco use

Identifiers

PMID27637337
PMCPMC5028119

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.